We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-1.85%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+871.56%
AUM
$865B
AUM Growth
-$62.5B
Cap. Flow
-$15.6B
Cap. Flow %
-1.8%
Top 10 Hldgs %
34.38%
Holding
3,202
New
115
Increased
2,022
Reduced
804
Closed
71

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$1.82B
2
SE icon
Sea Limited
SE
+$1.38B
3
CSCO icon
Cisco
CSCO
+$1.16B
4
NFLX icon
Netflix
NFLX
+$1.14B
5
IR icon
Ingersoll Rand
IR
+$1.03B

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.54B
2
AMZN icon
Amazon
AMZN
+$1.75B
3
APH icon
Amphenol
APH
+$1.65B
4
KLAC icon
KLA
KLAC
+$1.5B
5
XEL icon
Xcel Energy
XEL
+$1.38B

Sector Composition

Rank Sector Weight
1 Technology 33.6%
2 Financials 11.17%
3 Healthcare 11.1%
4 Communication Services 10.25%
5 Consumer Discretionary 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPAI
3051
Safe Pro Group Inc
SPAI
$90.8M
$59K ﹤0.01%
15,400
– –
NGEN
3052
NervGen Pharma
NGEN
$206M
$59K ﹤0.01%
+15,504
New +$67.2K
SKYX icon
3053
SKYX Platforms
SKYX
$153M
$58K ﹤0.01%
51,195
+20,084
+65% +$41.9K
RVSB icon
3054
Riverview Bancorp
RVSB
$119M
$57K ﹤0.01%
10,324
– –
SPWR icon
3055
SunPower Inc
SPWR
$62.7M
$57K ﹤0.01%
44,520
+14,031
+46% +$21.1K
GME.WS
3056
GameStop Corp Warrants
GME.WS
$56K ﹤0.01%
14,285
– –
FF icon
3057
Future Fuel
FF
$222M
$55K ﹤0.01%
14,047
– –
FLNA
3058
Filana Therapeutics
FLNA
$44.7M
$54K ﹤0.01%
31,368
– –
SPRU icon
3059
Spruce Power Holding Corp
SPRU
$34.5M
$54K ﹤0.01%
13,130
– –
STIM icon
3060
Neuronetics
STIM
$180M
$54K ﹤0.01%
36,861
– –
STKS icon
3061
The ONE Group
STKS
$52.9M
$54K ﹤0.01%
30,305
– –
SDST
3062
Stardust Power Inc
SDST
$1.51M
$54K ﹤0.01%
22,500
– –
DERM icon
3063
Journey Medical
DERM
$183M
$53K ﹤0.01%
+11,215
New +$87.1K
PNBK icon
3064
Patriot National Bancorp
PNBK
$120M
$49K ﹤0.01%
37,489
+15,053
+67% +$21.7K
BNC
3065
CEA Industries
BNC
$242M
$47K ﹤0.01%
15,900
– –
CLAR icon
3066
Clarus
CLAR
$131M
$46K ﹤0.01%
16,564
– –
DFDV
3067
DeFi Development Corp
DFDV
$182M
$46K ﹤0.01%
13,900
– –
GOSS icon
3068
Gossamer Bio
GOSS
$70.8M
$44K ﹤0.01%
1,650
+236
+17% +$29.7K
ARQ icon
3069
Arq
ARQ
$83.4M
$44K ﹤0.01%
16,868
– –
BRCC icon
3070
BRC Inc
BRCC
$131M
$43K ﹤0.01%
5,469
– –
LPSN
3071
DELISTED
LivePerson
LPSN
$43K ﹤0.01%
16,600
– –
VERU icon
3072
Veru
VERU
$43.6M
$43K ﹤0.01%
19,011
– –
PHUN icon
3073
Phunware
PHUN
$40.5M
$40K ﹤0.01%
22,072
– –
HFFG icon
3074
HF Foods Group
HFFG
$87.9M
$39K ﹤0.01%
20,931
– –
MNTK icon
3075
Montauk Renewables
MNTK
$418M
$39K ﹤0.01%
33,876
– –

Similar funds

T. Rowe Price Associates's Q1 2026 Portfolio in Review

As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.

  • T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
  • T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
  • T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
  • T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
  • T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
  • T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
  • T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.